Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001096906-12-002468
Filing Date
2012-09-28
Accepted
2012-09-28 15:55:56
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC 10QA1 2011-12-31 aoxingpharma10qa1.htm 10-Q/A 937613
2 RULE 13A-14(A) CERTIFICATION ? CEO aoxingpharmaexh311.htm EX-31.1 9385
3 RULE 13A-14(A) CERTIFICATION ? CFO aoxingpharmaexh312.htm EX-31.2 9320
4 RULE 13A-14(B) CERTIFICATION aoxingpharmaexh32.htm EX-32 4971
  Complete submission text file 0001096906-12-002468.txt   3443187

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT axn-20111231.xml EX-101.INS 645627
6 XBRL SCHEMA DOCUMENT axn-20111231.xsd EX-101.SCH 11760
7 XBRL CALCULATION LINKBASE DOCUMENT axn-20111231_cal.xml EX-101.CAL 7205
8 XBRL DEFINITION LINKBASE DOCUMENT axn-20111231_def.xml EX-101.DEF 54507
9 XBRL LABELS LINKBASE DOCUMENT axn-20111231_lab.xml EX-101.LAB 91436
10 XBRL PRESENTATION LINKBASE DOCUMENT axn-20111231_pre.xml EX-101.PRE 71996
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 001-32674 | Film No.: 121116619
SIC: 2834 Pharmaceutical Preparations